Zinc nutritional status modulates expression of AhR-responsive P450 enzymes in vascular endothelial cells

Environmental Toxicology and Pharmacology

Volumn 25, Issue 2, 2008, Pages 197-201

  Shen, Huiyun ^a,b   Arzuaga, Xabier ^a   Toborek, Michal ^b,c   Hennig, Bernhard ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

AhR; CYP1A1; CYP1B1; EROD; Zinc deficiency

Indexed keywords

3,3',4,4' TETRACHLOROBIPHENYL; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; CHELATING AGENT; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; MESSENGER RNA; XENOBIOTIC AGENT; ZINC;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE INDUCTION; HOMEOSTASIS; MEASUREMENT; MEMBRANE PERMEABILITY; NONHUMAN; NUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; SUPPLEMENTATION; UPREGULATION; VASCULAR ENDOTHELIUM; ZINC DEFICIENCY;

EID: 38349092326     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2007.10.016     Document Type: Article

References (30)

1. Chun Y.S., Choi E., Yeo E.J., Lee J.H., Kim M.S., and Park J.W. A new HIF-1 alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses. J. Cell Sci. 114 Pt. 22 (2001) 4051-4061
2. Cousins R.J., Blanchard R.K., Moore J.B., Cui L., Green C.L., Liuzzi J.P., Cao J., and Bobo J.A. Regulation of zinc metabolism and genomic outcomes. J. Nutr. 133 5 Suppl. 1 (2003) 1521S-1526S
3. Denison M.S., and Deal R.M. The binding of transformed aromatic hydrocarbon (Ah) receptor to its DNA recognition site is not affected by metal depletion. Mol. Cell. Endocrinol. 69 1 (1990) 51-57
4. Duffy J.Y., Overmann G.J., Keen C.L., Clegg M.S., and Daston G.P. Cardiac abnormalities induced by zinc deficiency are associated with alterations in the expression of genes regulated by the zinc-finger transcription factor GATA-4. Birth Defects Res. B Dev. Reprod. Toxicol. 71 2 (2004) 102-109
5. Fernandez-Salguero P.M., Ward J.M., Sundberg J.P., and Gonzalez F.J. Lesions of aryl-hydrocarbon receptor-deficient mice. Vet. Pathol. 34 6 (1997) 605-614
6. Fujii-Kuriyama Y., and Mimura J. Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem. Biophys. Res. Commun. 338 1 (2005) 311-317
7. Hennig B., Shasby D.M., Fulton A.B., and Spector A.A. Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis 4 5 (1984) 489-497
8. Ichihara S., Obata K., Yamada Y., Nagata K., Noda A., Ichihara G., Yamada A., Kato T., Izawa H., Murohara T., et al. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors. J. Mol. Cell. Cardiol. 41 2 (2006) 318-329
9. Ikuta T., and Kawajiri K. Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor. Exp. Cell. Res. 312 18 (2006) 3585-3594
10. Klug A., and Schwabe J.W. Protein motifs. 5. Zinc fingers. FASEB J. 9 8 (1995) 597-604
11. Kobayashi A., Sogawa K., and Fujii-Kuriyama Y. Cooperative interaction between AhR.Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene. J. Biol. Chem. 271 21 (1996) 12310-12316
12. Kroncke K.D., and Carlberg C. Inactivation of zinc finger transcription factors provides a mechanism for a gene regulatory role of nitric oxide. FASEB J. 14 1 (2000) 166-173
13. Li L., He S., Sun J.M., and Davie J.R. Gene regulation by Sp1 and Sp3. Biochem. Cell. Biol. 82 4 (2004) 460-471
14. Linke K., Wolfram T., Bussemer J., and Jakob U. The roles of the two zinc binding sites in DnaJ. J. Biol. Chem. 278 45 (2003) 44457-44466
15. Lund A.K., Goens M.B., Kanagy N.L., and Walker M.K. Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicol. Appl. Pharmacol. 193 2 (2003) 177-187
16. Lund A.K., Goens M.B., Nunez B.A., and Walker M.K. Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice. Toxicol. Appl. Pharmacol. 212 2 (2006) 127-135
17. Mahon M.J., and Gasiewicz T.A. Chelatable metal ions are not required for aryl hydrocarbon receptor transformation to a DNA binding form: phenanthrolines are possible competitive antagonists of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys. 297 1 (1992) 1-8
18. Puga A., Tomlinson C.R., and Xia Y. Ah receptor signals cross-talk with multiple developmental pathways. Biochem. Pharmacol. 69 2 (2005) 199-207
19. Ramadass P., Meerarani P., Toborek M., Robertson L.W., and Hennig B. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol. Sci. 76 1 (2003) 212-219
20. Reiterer G., Toborek M., and Hennig B. Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. J. Nutr. 134 7 (2004) 1711-1715
21. Reiterer G., Toborek M., and Hennig B. Zinc and cell signaling during inflammation: implications in atherosclerosis. Curr. Nutr. Food Sci. 2 (2006) 23-28
22. 2+ requirement. J. Biol. Chem. 265 16 (1990) 9251-9258
23. Savouret J.F., Berdeaux A., and Casper R.F. The aryl hydrocarbon receptor and its xenobiotic ligands: a fundamental trigger for cardiovascular diseases. Nutr. Metab. Cardiovasc. Dis. 13 2 (2003) 104-113
24. Shi Y., and Berg J.M. Specific DNA-RNA hybrid binding by zinc finger proteins. Science 268 5208 (1995) 282-284
25. Slim R., Toborek M., Robertson L.W., and Hennig B. Antioxidant protection against PCB-mediated endothelial cell activation. Toxicol. Sci. 52 2 (1999) 232-239
26. Stegeman J.J., Hahn M.E., Weisbrod R., Woodin B.R., Joy J.S., Najibi S., and Cohen R.A. Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells. Mol. Pharmacol. 47 2 (1995) 296-306
27. Suske G. The Sp-family of transcription factors. Gene 238 2 (1999) 291-300
28. Thiesen H.J., and Bach C. Transition metals modulate DNA-protein interactions of SP1 zinc finger domains with its cognate target site. Biochem. Biophys. Res. Commun. 176 2 (1991) 551-557
29. Wu X., Bishopric N.H., Discher D.J., Murphy B.J., and Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol. 16 3 (1996) 1035-1046
30. Xin M., Davis C.A., Molkentin J.D., Lien C.L., Duncan S.A., Richardson J.A., and Olson E.N. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc. Natl. Acad. Sci. U.S.A. 103 30 (2006) 11189-11194